AbbVie
Price & Volume
Stats
See moreOpen | $277.38 |
Previous Close | $276.47 |
Day Range | $276.13-$280.72 |
52W Range | $189.40-$277.60 |
Market Cap | $488.5B |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $64.3B |
Revenue Growth (YoY) | 10.2% |
Gross Profit (12 Mos) | $46.8B |
Diluted EPS | $3.54 |
News
See moreYahoo Finance • 8 hours ago
REGENXBIO to Host Investor Event Highlighting Surabgene Lomparvovec (Sura-vec) in Wet AMD on October 20
Yahoo Finance • yesterday
New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease
Yahoo Finance • 2 days ago
Hospital group files lawsuit to stop 340B rebate pilot again
Yahoo Finance • 3 days ago
What Does AbbVie (ABBV) Winning Two FDA Breakthrough Tags Mean For Its Oncology Pipeline?
About
CEO | Mr. Robert A. Michael CPA |
CFO | Mr. Scott T. Reents |
Address | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 57,000 |